Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Ashvattha Therapeutics
1235 Radio Road, Suite 200
Redwood City, CA 94065
Phone: 650-868-5853
https://avttx.com/

Ashvattha Therapeutics is a clinical-stage biotech company developing novel hydroxyl dendrimer therapeutics (HDTs) targeting unmet medical needs in ophthalmology, neurology, inflammation and neuro-oncology. The therapies are based on hydroxyl dendrimers (HDs), a targeted platform technology exclusively licensed from firm founders, Kannan Rangaramanujam and Sujatha Kannan at Johns Hopkins University.

Key Contact
Name
Jeffrey Cleland
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
04/28/22 $69,000,000 Series B Huadong Medicine Investment Holding Co.
Natural Capital
Plum Alley Investments
Tribe Capital
undisclosed